ClinicalTrials.gov
ClinicalTrials.gov Menu

A Novel Drug for Borderline Personality Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02097706
Recruitment Status : Recruiting
First Posted : March 27, 2014
Last Update Posted : January 11, 2018
Sponsor:
Information provided by (Responsible Party):
Jayashri Kulkarni, Professor, The Alfred

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2018
  Estimated Study Completion Date : December 2018